• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种强效且选择性的 PARP11 抑制剂提示细胞定位和催化活性之间的偶联。

A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity.

机构信息

Program in Chemical Biology, Oregon Health & Science University, Portland, OR 97210, USA; Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR 97210, United States.

European Molecular Biology Laboratory (EMBL), Cell Biology and Biophysics Unit, Meyerhofstrasse 1, 69117 Heidelberg, Germany; EMBL, Heidelberg University, Heidelberg, Germany.

出版信息

Cell Chem Biol. 2018 Dec 20;25(12):1547-1553.e12. doi: 10.1016/j.chembiol.2018.09.011. Epub 2018 Oct 18.

DOI:10.1016/j.chembiol.2018.09.011
PMID:30344052
Abstract

Poly-ADP-ribose polymerases (PARPs1-16) play pivotal roles in diverse cellular processes. PARPs that catalyze poly-ADP-ribosylation (PARylation) are the best characterized PARP family members because of the availability of potent and selective inhibitors for these PARPs. There has been comparatively little success in developing selective small-molecule inhibitors of PARPs that catalyze mono-ADP-ribosylation (MARylation), limiting our understanding of the cellular role of MARylation. Here we describe the structure-guided design of inhibitors of PARPs that catalyze MARylation. The most selective analog, ITK7, potently inhibits the MARylation activity of PARP11, a nuclear envelope-localized PARP. ITK7 is greater than 200-fold selective over other PARP family members. Using live-cell imaging, we show that ITK7 causes PARP11 to dissociate from the nuclear envelope. These results suggest that the cellular localization of PARP11 is regulated by its catalytic activity.

摘要

多聚 ADP 核糖聚合酶(PARPs1-16)在多种细胞过程中发挥关键作用。由于存在针对这些 PARPs 的有效且选择性抑制剂,因此催化多聚 ADP 核糖基化(PARylation)的 PARPs 是最具特征的 PARP 家族成员。然而,开发选择性的小分子抑制剂来抑制催化单 ADP 核糖基化(MARylation)的 PARPs 方面相对较少,这限制了我们对 MARylation 细胞功能的理解。在这里,我们描述了催化 MARylation 的 PARPs 抑制剂的结构导向设计。最具选择性的类似物 ITK7 可强烈抑制定位于核膜的 PARP11 的 MARylation 活性。ITK7 对其他 PARP 家族成员的选择性大于 200 倍。通过活细胞成像,我们表明 ITK7 导致 PARP11 从核膜解离。这些结果表明 PARP11 的细胞定位受其催化活性调节。

相似文献

1
A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity.一种强效且选择性的 PARP11 抑制剂提示细胞定位和催化活性之间的偶联。
Cell Chem Biol. 2018 Dec 20;25(12):1547-1553.e12. doi: 10.1016/j.chembiol.2018.09.011. Epub 2018 Oct 18.
2
Chemical genetic methodologies for identifying protein substrates of PARPs.鉴定 PARPs 蛋白底物的化学遗传学方法。
Trends Biochem Sci. 2022 May;47(5):390-402. doi: 10.1016/j.tibs.2021.07.002. Epub 2021 Aug 5.
3
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.通过检测单 ADP-核糖基化来实现 PARP 蛋白家族的药物发现。
Biochem Pharmacol. 2019 Sep;167:97-106. doi: 10.1016/j.bcp.2019.05.007. Epub 2019 May 7.
4
Mechanisms governing PARP expression, localization, and activity in cells.细胞中 PARP 表达、定位和活性的调控机制。
Crit Rev Biochem Mol Biol. 2020 Dec;55(6):541-554. doi: 10.1080/10409238.2020.1818686. Epub 2020 Sep 23.
5
Rational Design of Cell-Active Inhibitors of PARP10.PARP10细胞活性抑制剂的合理设计。
ACS Med Chem Lett. 2018 Nov 29;10(1):74-79. doi: 10.1021/acsmedchemlett.8b00429. eCollection 2019 Jan 10.
6
Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics.小分子 PARP 抑制剂:从 ADP-核糖基化研究工具到治疗药物。
Curr Top Microbiol Immunol. 2019;420:211-231. doi: 10.1007/82_2018_137.
7
Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.聚(ADP-核糖)聚合酶抑制剂Zj6413,作为一种潜在的抗乳腺癌治疗药物。
Biochem Pharmacol. 2016 May 1;107:29-40. doi: 10.1016/j.bcp.2016.02.015. Epub 2016 Feb 24.
8
A Simple, Sensitive, and Generalizable Plate Assay for Screening PARP Inhibitors.一种用于筛选聚(ADP-核糖)聚合酶(PARP)抑制剂的简单、灵敏且可推广的平板检测法。
Methods Mol Biol. 2018;1813:245-252. doi: 10.1007/978-1-4939-8588-3_17.
9
The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.PARPs 和 ADP-ribosylation 对炎症和宿主-病原体相互作用的影响。
Genes Dev. 2020 Mar 1;34(5-6):341-359. doi: 10.1101/gad.334425.119. Epub 2020 Feb 6.
10
Crystal structures of the catalytic domain of human PARP15 in complex with small molecule inhibitors.人 PARP15 催化结构域与小分子抑制剂复合物的晶体结构。
Biochem Biophys Res Commun. 2022 Sep 24;622:93-100. doi: 10.1016/j.bbrc.2022.06.070. Epub 2022 Jul 4.

引用本文的文献

1
Interferon-induced PARP14-mediated ADP-ribosylation in p62 bodies requires the ubiquitin-proteasome system.干扰素诱导的PARP14介导的p62小体中的ADP核糖基化需要泛素-蛋白酶体系统。
EMBO J. 2025 May;44(10):2741-2773. doi: 10.1038/s44318-025-00421-4. Epub 2025 Apr 7.
2
PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease.PARP7抑制I型干扰素信号传导以预防自身免疫和肺部疾病。
J Exp Med. 2025 May 5;222(5). doi: 10.1084/jem.20241184. Epub 2025 Feb 19.
3
Pathological and physiological roles of ADP-ribosylation: established functions and new insights.
ADP核糖基化的病理和生理作用:既定功能与新见解
Biol Chem. 2024 Jul 29. doi: 10.1515/hsz-2024-0057.
4
PARP11 inhibition inactivates tumor-infiltrating regulatory T cells and improves the efficacy of immunotherapies.PARP11抑制可使肿瘤浸润调节性T细胞失活,并提高免疫疗法的疗效。
Cell Rep Med. 2024 Jul 16;5(7):101649. doi: 10.1016/j.xcrm.2024.101649.
5
Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms.单 ADP 核糖基化,一种对蛋白质、DNA 和 RNA 的多方面修饰:特性、功能及机制
Cell Death Discov. 2024 May 11;10(1):226. doi: 10.1038/s41420-024-01994-5.
6
ADP-ribosylation from molecular mechanisms to therapeutic implications.ADP-核糖基化:从分子机制到治疗意义。
Cell. 2023 Oct 12;186(21):4475-4495. doi: 10.1016/j.cell.2023.08.030.
7
Immunomodulatory roles of PARPs: Shaping the tumor microenvironment, one ADP-ribose at a time.聚腺苷二磷酸核糖聚合酶(PARPs)的免疫调节作用:每次通过一个 ADP-核糖基来塑造肿瘤微环境。
Curr Opin Chem Biol. 2023 Dec;77:102402. doi: 10.1016/j.cbpa.2023.102402. Epub 2023 Oct 4.
8
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs.具有优势的支架可用于强效且特异性的单 ADP-核糖基化 PARPs 抑制剂。
Molecules. 2023 Aug 3;28(15):5849. doi: 10.3390/molecules28155849.
9
Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance.解析 PARP1 在维持体内平衡和肿瘤发生中的作用:对癌症治疗和克服耐药性的影响。
Cells. 2023 Jul 21;12(14):1904. doi: 10.3390/cells12141904.
10
[1,2,4]Triazolo[3,4-]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes.三唑并[3,4-b]噻唑作为多功能烟酰胺类似物骨架,可实现对不同 PARP 酶的纳摩尔抑制作用。
J Med Chem. 2023 Jan 26;66(2):1301-1320. doi: 10.1021/acs.jmedchem.2c01460. Epub 2023 Jan 4.